The role of PLZF in regulating the antiviral activity of interferons

Williams, Bryan (Primary Chief Investigator (PCI))
Xu, Dakang (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/10 → 31/12/13

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$622,800.00

2 Article

BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs
Sadler, A. J., Rossello, F. J., Yu, L., Deane, J. A., Yuan, X-L., Wang, D., Irving, A. T., Liaskos, M., Gantier, M. P. M., Ying, H., Yim, H. C. H., Hartland, E. L., Notini, A. J., De Boer, C. M., White, S., Mansell, A. S., Liu, J-P., Watkins, D. N., Gerondakis, S. D., Williams, B. R. G., & 1 othersXu, D., 2015, In: Proceedings of the National Academy of Sciences of the United States of America. 112, 5, p. 1535 - 1540 6 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

44 Citations (Scopus)
Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling
Ma, Y., Yuan, X., Deng, L., Xu, W., Zheng, Y., Yue, C., Zhang, G., Xie, F., Yang, Y. H., Gantier, M. P. M., Liu, J-P., Xu, D. & Shen, L., 2013, In: PLoS ONE. 8, 8 (art. no. e72804), p. 1 - 12 12 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

19 Citations (Scopus)